High-Sensitive Troponin T, Natriuretic Peptide, and Cognitive Change.


Journal

Journal of the American Geriatrics Society
ISSN: 1532-5415
Titre abrégé: J Am Geriatr Soc
Pays: United States
ID NLM: 7503062

Informations de publication

Date de publication:
11 2019
Historique:
received: 03 05 2019
revised: 24 06 2019
accepted: 26 06 2019
pubmed: 31 7 2019
medline: 22 5 2020
entrez: 31 7 2019
Statut: ppublish

Résumé

Cardiac troponin T, measured using a high-sensitive assay (hs-cTnT), and N-terminal pro-B-type natriuretic peptide (NT-proBNP) are associated with increased stroke risk and perhaps with cognitive decline. However, few well-designed prospective studies with extended follow-up have been conducted. We aimed to estimate the association of hs-cTnT and NT-proBNP with 15-year cognitive change in the Atherosclerosis Risk in Communities (ARIC) study. Prospective cohort study. Four US communities. A total of 9114 and 9108 participants from the Atherosclerosis Risk in Communities study for analyses of hs-cTnT and NT-proBNP, respectively. We examined association of hs-cTnT and NT-proBNP with 15-year change (1996-1998 to 2011-2013) in three cognitive tests of executive function (Digit Symbol Substitution Test), verbal learning memory (Delayed Word Recall Test), and semantic fluency (Word Fluency Test), and an overall score combining the three tests using multivariable linear mixed effect models. We conducted several sensitivity analyses including multiple imputations to address bias due to missing data and attrition, and we compared associations within groups combining hs-cTnT and NT-proBNP into a three-level categorical variable. At baseline (1996-1998), mean age was 63.4 (standard deviation [SD] = 5.7) years; 56.4% were women, and 17.5% were black. The hs-cTnT at baseline was not associated with cognitive change in any measure. Some evidence indicated accelerated decline in verbal learning and memory when comparing those in the highest with the lowest NT-proBNP quintiles; however, this association was not replicated when considering clinically relevant cutoffs or deciles of exposure in survivors. Sensitivity analyses were consistent with our primary analyses. There was little evidence to support effect modification by any considered factors. People with highest levels of both biomarkers had excessive decline in global z scores vs people with lowest levels (-.34; 95% confidence interval = -.63 to -.04). Markers of myocardial injury and stretch were not associated with cognitive decline following 15 years among survivors, but when combined together they were suggestive in post hoc analysis. Whether this represents targets of intervention should be examined in the future. J Am Geriatr Soc 67:2353-2361, 2019.

Identifiants

pubmed: 31359423
doi: 10.1111/jgs.16092
pmc: PMC6861618
mid: NIHMS1045307
doi:

Substances chimiques

Biomarkers 0
Peptide Fragments 0
Protein Precursors 0
Troponin T 0
pro-brain natriuretic peptide (1-76) 0
Natriuretic Peptide, Brain 114471-18-0

Types de publication

Journal Article Multicenter Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2353-2361

Subventions

Organisme : NHLBI NIH HHS
ID : U01 HL096812
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01-HL70825
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL096917
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK089174
Pays : United States
Organisme : NHLBI NIH HHS
ID : HL096899
Pays : United States
Organisme : HHS
ID : HHSN268201700002I
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL096902
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700001I
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL096814
Pays : United States
Organisme : HHS
ID : HHSN268201700003I
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL134320
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700003I
Pays : United States
Organisme : NHLBI NIH HHS
ID : HL096902
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32HL110837
Pays : United States
Organisme : NHLBI NIH HHS
ID : HL096814
Pays : United States
Organisme : NHLBI NIH HHS
ID : HL096917
Pays : United States
Organisme : NIA NIH HHS
ID : R03 AG055485
Pays : United States
Organisme : HHS
ID : HHSN268201700005I
Pays : United States
Organisme : HHS
ID : HHSN268201700001I
Pays : United States
Organisme : NINDS NIH HHS
ID : R25 NS065729
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700002C
Pays : United States
Organisme : NHLBI NIH HHS
ID : K24 HL148521
Pays : United States
Organisme : NIDDK NIH HHS
ID : K24 DK106414
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700004I
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL110837
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700005C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700003C
Pays : United States
Organisme : NIH HHS
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700001C
Pays : United States
Organisme : HHS
ID : HHSN268201700004I
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL070825
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL096899
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700004C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700002I
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700005I
Pays : United States

Informations de copyright

© 2019 The American Geriatrics Society.

Références

Stroke. 2011 Sep;42(9):2672-713
pubmed: 21778438
Clin Chem. 2013 Dec;59(12):1802-10
pubmed: 24036936
Am J Epidemiol. 1989 Apr;129(4):687-702
pubmed: 2646917
Alzheimers Dement. 2018 Feb;14(2):167-177
pubmed: 28916238
JAMA Neurol. 2014 Oct;71(10):1218-27
pubmed: 25090106
Circulation. 2012 May 1;125(17):2100-7
pubmed: 22456473
PLoS One. 2012;7(9):e44569
pubmed: 22973461
J Alzheimers Dis. 2009;17(4):807-15
pubmed: 19542620
Medicine (Baltimore). 2015 Jan;94(1):e297
pubmed: 25569645
N Engl J Med. 2009 Aug 27;361(9):858-67
pubmed: 19710484
Circulation. 2011 Apr 5;123(13):1367-76
pubmed: 21422391
Int J Behav Nutr Phys Act. 2008 Dec 17;5:68
pubmed: 19091124
JAMA. 2010 Dec 8;304(22):2494-502
pubmed: 21078811
Eur J Epidemiol. 2017 Jan;32(1):55-66
pubmed: 27619926
Neurology. 2014 Sep 23;83(13):1192-9
pubmed: 25142900
J Alzheimers Dis. 2016 Nov 1;55(1):359-369
pubmed: 27636851
Circulation. 2011 May 10;123(18):2015-9
pubmed: 21555724
Ann Epidemiol. 2013 Feb;23(2):66-73
pubmed: 23228375
JAMA Neurol. 2017 Oct 1;74(10):1246-1254
pubmed: 28783817
Am J Epidemiol. 2001 Jan 1;153(1):72-8
pubmed: 11159149
Stroke. 2013 Apr;44(4):961-7
pubmed: 23471272
Stroke. 2013 Jul;44(7):1803-8
pubmed: 23660848
J Alzheimers Dis. 2015;44(3):1007-13
pubmed: 25408211
J Neurol. 2017 Mar;264(3):503-511
pubmed: 28039523
Eur Heart J. 2014 Jul 14;35(27):1817-24
pubmed: 24685712
N Engl J Med. 2004 Feb 12;350(7):655-63
pubmed: 14960742
Eur J Prev Cardiol. 2016 Sep;23(13):1383-92
pubmed: 26884081
Circulation. 2009 Dec 1;120(22):2177-87
pubmed: 19917883
Arch Neurol. 1989 Feb;46(2):141-5
pubmed: 2916953
Circulation. 2008 Feb 12;117(6):754-61
pubmed: 18212291
Am J Med. 2011 Jul;124(7):670.e1-8
pubmed: 21683832
Eur J Heart Fail. 2004 Mar 15;6(3):257-60
pubmed: 14987573
Hypertension. 2015 Jan;65(1):78-84
pubmed: 25350984
Obesity (Silver Spring). 2011 Sep;19(9):1866-72
pubmed: 21593801
Radiology. 2017 Apr;283(1):205-214
pubmed: 27924720
J Neurol Neurosurg Psychiatry. 2016 Apr;87(4):356-62
pubmed: 25918047
Ann Intern Med. 2014 Dec 2;161(11):785-93
pubmed: 25437406
Alzheimers Dement. 2018 Nov;14(11):1493-1504
pubmed: 29494808
Alzheimers Dement. 2011 May;7(3):280-92
pubmed: 21514248

Auteurs

Yashashwi Pokharel (Y)

Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City, Kansas City, Missouri.

Farah Mouhanna (F)

Department of Epidemiology and Biostatistics, Milken Institute School of Public Health, The George Washington University, Washington, District of Columbia.
Department of Behavioral Sciences and Health Education, Rollins School of Public Health, Emory University, Atlanta, Georgia.

Andrea L C Schneider (ALC)

Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Andreea M Rawlings (AM)

Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland.

David S Knopman (DS)

Department of Neurology, Mayo Clinic, Rochester, Minnesota.

Vijay Nambi (V)

Department of Medicine, Section of Cardiovascular Research, Baylor College of Medicine, Houston, Texas.
Center for Cardiovascular Disease Prevention, Houston Methodist DeBakey Heart and Vascular Center, Houston, Texas.
Section of Cardiology, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas.

Salim S Virani (SS)

Department of Medicine, Section of Cardiovascular Research, Baylor College of Medicine, Houston, Texas.
Center for Cardiovascular Disease Prevention, Houston Methodist DeBakey Heart and Vascular Center, Houston, Texas.
Section of Cardiology, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas.

Ron C Hoogeveen (RC)

Department of Medicine, Section of Cardiovascular Research, Baylor College of Medicine, Houston, Texas.

Alvaro Alonso (A)

Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia.

Gerardo Heiss (G)

Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina.

Josef Coresh (J)

Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland.

Thomas Mosley (T)

Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi.

Rebecca Gottesman (R)

Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland.

Elizabeth Selvin (E)

Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland.

Christie Ballantyne (C)

Department of Medicine, Section of Cardiovascular Research, Baylor College of Medicine, Houston, Texas.
Center for Cardiovascular Disease Prevention, Houston Methodist DeBakey Heart and Vascular Center, Houston, Texas.

Melinda C Power (MC)

Department of Epidemiology and Biostatistics, Milken Institute School of Public Health, The George Washington University, Washington, District of Columbia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH